Form 4: Cencora Director Lauren M. Tyler Acquires Shares in Lieu of Cash Retainer

Director Lauren M. Tyler acquired 103 shares of Cencora, Inc. common stock on August 1, 2024, in lieu of a $25,000 quarterly cash retainer.

Summary

• On August 1, 2024, Lauren M. Tyler, a director of Cencora, Inc., acquired 103 shares of common stock.
• The acquisition was made in lieu of a $25,000 quarterly cash retainer, as part of the company's Non-Employee Director Compensation Program.
• The price per share was $244.46.
• Following the transaction, Tyler directly owns 1,776 shares of Cencora common stock.
• Delivery of vested shares is deferred until March 1, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director taking shares in lieu of cash is generally seen as a good sign, indicating confidence in the company's stock.

Positives

• A director's decision to take shares in lieu of cash may signal confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Director share acquisitions are common and are often viewed as a positive sign, indicating the director's belief in the company's prospects. This transaction is part of Cencora's compensation program for non-employee directors.

Comparison to Industry Standards

• Director compensation packages vary across the pharmaceutical distribution industry.
• Companies like McKesson and Cardinal Health also use a mix of cash and equity in their director compensation programs.
• The specific mix depends on company size, performance, and governance practices.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment, as it signals director confidence.

Key Dates